IBL HealthCare Limited (PSX: IBLHL)
Pakistan
· Delayed Price · Currency is PKR
41.60
+3.78 (9.99%)
At close: Nov 14, 2024
IBL HealthCare Income Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
Revenue | 3,621 | 3,603 | 4,028 | 3,651 | 3,004 | 2,665 | Upgrade
|
Revenue Growth (YoY) | -11.46% | -10.54% | 10.32% | 21.55% | 12.73% | 68.12% | Upgrade
|
Cost of Revenue | 2,685 | 2,654 | 2,691 | 2,400 | 1,985 | 1,857 | Upgrade
|
Gross Profit | 935.84 | 949.32 | 1,336 | 1,251 | 1,019 | 807.59 | Upgrade
|
Selling, General & Admin | 796.59 | 795.96 | 726.7 | 680.77 | 606.06 | 508.47 | Upgrade
|
Other Operating Expenses | 7.25 | - | - | - | - | - | Upgrade
|
Operating Expenses | 803.84 | 795.96 | 726.7 | 680.77 | 612.19 | 508.47 | Upgrade
|
Operating Income | 132 | 153.35 | 609.68 | 570.69 | 406.77 | 299.12 | Upgrade
|
Interest Expense | -59.83 | -65.43 | -64.14 | -25.7 | -26.34 | -29.93 | Upgrade
|
Interest & Investment Income | - | - | - | - | 10.47 | 30.57 | Upgrade
|
Currency Exchange Gain (Loss) | 22.94 | 27.18 | -109.57 | -72.83 | 3.87 | 1.11 | Upgrade
|
Other Non Operating Income (Expenses) | 3.7 | 3.7 | 22.86 | 9.81 | 13.09 | 20.93 | Upgrade
|
EBT Excluding Unusual Items | 98.8 | 118.8 | 458.82 | 481.97 | 407.87 | 321.81 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | 0.01 | 1.92 | - | - | Upgrade
|
Asset Writedown | -10.1 | -10.1 | - | -0.62 | - | - | Upgrade
|
Pretax Income | 88.7 | 108.7 | 458.83 | 483.27 | 409.15 | 321.81 | Upgrade
|
Income Tax Expense | 101.19 | 101.15 | 149.87 | 180.41 | 108.66 | 101.78 | Upgrade
|
Net Income | -12.49 | 7.56 | 308.96 | 302.86 | 300.49 | 220.03 | Upgrade
|
Net Income to Common | -12.49 | 7.56 | 308.96 | 302.86 | 300.49 | 220.03 | Upgrade
|
Net Income Growth | - | -97.55% | 2.02% | 0.79% | 36.57% | 81.28% | Upgrade
|
Shares Outstanding (Basic) | 86 | 86 | 86 | 86 | 86 | 86 | Upgrade
|
Shares Outstanding (Diluted) | 86 | 86 | 86 | 86 | 86 | 86 | Upgrade
|
Shares Change (YoY) | -0.01% | - | -0.00% | 0.00% | -0.00% | - | Upgrade
|
EPS (Basic) | -0.15 | 0.09 | 3.61 | 3.53 | 3.51 | 2.57 | Upgrade
|
EPS (Diluted) | -0.15 | 0.09 | 3.61 | 3.53 | 3.51 | 2.57 | Upgrade
|
EPS Growth | - | -97.55% | 2.02% | 0.79% | 36.57% | 81.28% | Upgrade
|
Free Cash Flow | -4.33 | 566.44 | 24.34 | 55.56 | 65.09 | 36.37 | Upgrade
|
Free Cash Flow Per Share | -0.05 | 6.61 | 0.28 | 0.65 | 0.76 | 0.42 | Upgrade
|
Dividend Per Share | - | - | - | 0.757 | 0.631 | 1.263 | Upgrade
|
Dividend Growth | - | - | - | 19.99% | -50.00% | 100.00% | Upgrade
|
Gross Margin | 25.84% | 26.35% | 33.18% | 34.28% | 33.92% | 30.31% | Upgrade
|
Operating Margin | 3.65% | 4.26% | 15.14% | 15.63% | 13.54% | 11.23% | Upgrade
|
Profit Margin | -0.34% | 0.21% | 7.67% | 8.29% | 10.00% | 8.26% | Upgrade
|
Free Cash Flow Margin | -0.12% | 15.72% | 0.60% | 1.52% | 2.17% | 1.37% | Upgrade
|
EBITDA | 134.65 | 156.44 | 612.95 | 575.98 | 411.77 | 303.41 | Upgrade
|
EBITDA Margin | 3.72% | 4.34% | 15.22% | 15.78% | 13.71% | 11.39% | Upgrade
|
D&A For EBITDA | 2.65 | 3.09 | 3.28 | 5.29 | 5 | 4.29 | Upgrade
|
EBIT | 132 | 153.35 | 609.68 | 570.69 | 406.77 | 299.12 | Upgrade
|
EBIT Margin | 3.65% | 4.26% | 15.14% | 15.63% | 13.54% | 11.23% | Upgrade
|
Effective Tax Rate | 114.08% | 93.05% | 32.66% | 37.33% | 26.56% | 31.63% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.